The Biomedical Accelerator Fund is now accepting proposals for technology development projects in the life sciences. The pre-proposal deadline is Feb. 25, 2013.
Now in its seventh year, the fund has financed 37 projects from around the university with total grants of approximately $6.5 million. Typical awards will range between $150,000 and $200,000 per year (direct costs only, indirect costs are waived).
A significant obstacle to the development and transfer of university technologies is the lack of funding for proof-of-concept and validation studies, essential steps required to demonstrate commercial potential.
The Biomedical Accelerator Fund, established by the Office of Technology Development under the auspices of the Office of the Provost, is designed to overcome this barrier by providing funding assistance to faculty in the early stages of developing and validating nascent technologies originating in their labs with the goal of advancing projects beyond the bench and positioning them to attract strong industry partners who will continue to fund and develop them for commercial application and public access.
Anyone with rights as a principal investigator and whose employer is Harvard University is eligible to apply.
Additional details can be found on the Office of Technology Development website, at http://otd.harvard.edu/faculty/Biomedical_Accelerator_Guidelines_2013.pdf
Researchers can also contact curtis_keith@harvard.edu<mailto:curtis_keith@harvard.edu> with questions.
